Week 3 Sem 2 Med1022 Flashcards
Variation- 2 types of genetic mutation producing polymorphism
Single base mutation Variable length insertion/deletion
Pharmacogenetics
Study of how genetic differences influence the patient-drug interaction
Beta-2 adrenoreceptors
Receptor for salbutamol to cause bronchodilation n vasodilation Receptors may be mutated so become hyperresponsive (= initially great response but then becomes desensitised wit long term treatment ) Have to stop takin beta-2 agonists in long term
Metabolism of drugs
Metabolised by liver enzymes eg those part of CYP450 family Biotransformation Then leave the body
Gene for CYP450 r very polymorphic, thus can get these variations:
Deleted gene -no enzyme, no metabolism of drugs SNP-eg unstable enzyme (reduced metabolism) Normal enzyme Duplicated genes (higher enzyme levels, faster metabolism)
Some patients r CYP2D6 deficient
Slow metabolism Drug levels too high No prodrug activation
Some patients r CYP2D6 duplicants
Metabolism too fast
HER2
Human epidermal growth factor receptor 2 Tyrosine kinase receptor overexpressed in breast cancer Herceptin (monoclonal antibody) effective for this form of cancer, but not forms caused by other genetic mutations
Pharmacogenomics
Use of genetic info to guide drug therapy-dif in responses can be predicted if genetic makeup is known
Prospective efficacy
Using pharmacogenetics to select patients who r predicted to b responders/non-responders/hyper-responders to particular drug
Skeletal muscle
Regeneration: limited Voluntary movement Many nuclei peripherally Striated (due to sarcomeres)
structure of skeletal muscle
whole muscle (surrounded by epimysium) fascicles=bunches of muscle fibres (sur. by perimyiusm) each muscle fibre (sur. by endomysium) each muscle fibre has many myofibrils each myofibril has many myofilments myofilaments arranged into sarcomeres
sarcomere
segment bw 2 neighbouring Z-lines
I band
actin only
A band
entire length of myosin
H zone
myosin only
M line
proteins that form attachment site for myosin, half way through A band
Thin filaments
actin (+ tropomysin + TROPONIN)
tropomysin
long strand thingy that covers the active site on actin
troponin
has Ca2+ binding site
Thick filaments
myosin
myosin
globular heads are cross bridge projections each head has actin binding site n ATPase site
cross bridge cycle
- ATP splitting- BASICALLY ATP STUCK TO MYOSIN HEAD N IS CHOPPED IN HALF TO ADP AND PI 2. Attachment- BASICALLY CA2+ STICKS TO TROPONIN, CAUSING TROPOMYSIN TO EXPOSE ACTIVE SITES ON ACTIN 3. Power stroke- BASICALLY HEAD OF MYOSIN BINDS TO ACTIN, PULLING IT IN, using ENERGY FROM CHOPPING UP ATP BEFORE 4. Detachment- BASICALLY ADP AND Pi ARE RELEASED FROM MYOSIN HEAD. ANOTHER ATP ATTACHES TO MYOSIN HEAD. MYOSIN HEAD DETACHES FROM ACTIN. (THEN ATP IS SPLIT –CYCLE STARTS AGAIN)
notes for cross bridge cycle
ATP splitting occurs before any attachment to actin -to get myosin head ready to go. Need ATP to bind to myosin head before myosin head can let go off actin (STEP 4) otherwise, myosin head would get stuck on actin= cycle locks after step 3 hence Rigor Mortis (body becomes stiff after death)